The Breast Cancer Index (BCI) by Biotheranostics, Inc. San Diego, CA is a mix of two profiles: the antiapoptotic homeobox B13-to-interleukin 17B receptor expression ratio (H:I ratio), representing a 2-gene ratio, and the Molecular Grade Index, representing five proliferation genes (15). Here, IL17RB is linked to breast carcinoma.